NCT00592969View on ClinicalTrials.gov

Efficacy and Safety of Metformin Plus Biphasic Insulin Aspart 30 in Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL

Enrollment

164

Participants

Timeline

Start Date

December 3, 2003

Primary Completion Date

November 2, 2004

Study Completion Date

November 2, 2004

Conditions

DiabetesDiabetes Mellitus, Type 2

Interventions

DRUG

metformin

DRUG

biphasic insulin aspart

Trial Locations (2)

5016

Novo Nordisk Investigational Site, Mariano Acosta S/n

30150-320

Novo Nordisk Investigational Site, Santa Efigênia

Sponsors

Lead Sponsor

Novo Nordisk A/S

All Listed Sponsors

lead

Novo Nordisk A/S

INDUSTRY